Table: Kringle Pharma -2022/23 parent results

Kringle Pharma

13/11/2023 06:40

Nov 13 (Reuters)- 
          Kringle Pharma, Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended      Year ended        Year to         NEXT   
               Sep 30, 2023    Sep 30, 2022     Sep 30, 2024      YEAR     
                  LATEST         YEAR-AGO         COMPANY        COMPANY   
                 RESULTS          RESULTS         FORECAST     H1 FORECAST 
  Sales           69 mln          391 mln         272 mln                  
               (-82.3 pct)      (+35.2 pct)     (+292.8 pct)               
  Operating    loss 888 mln    loss 426 mln      loss 1.13                 
  Recurring    loss 852 mln    loss 330 mln      loss 1.11                 
  Net          loss 854 mln    loss 331 mln      loss 1.11                 
  EPS        loss 158.46 yen  loss 68.33 yen  loss 200.86 yen              
  Ann Div          NIL              NIL             NIL                    
  -Q2 Div          NIL              NIL             NIL                    
  -Q4 Div          NIL              NIL             NIL                    
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T